MDIN MedGen Inc (CE)

Med Gen Inc. (OTCBB:MDIN), manufacturers of nationally branded OTC healthier life products reports on a 30 Minute Infomercial featuring spokesperson Sunset Thomas pitching Med Gen�s newest product, FabULust� to 110 million households via a Pan-American shoppers network. The Astra East Satellite system will beam the commercial to all the EU countries and North Africa. The commercial will air starting in late August and continue into September 2008. �Products of this nature are very well received in the European markets and, although this has been an expensive project, I expect a substantial amount of business to be quickly generated,� said Paul Kravitz, Company Chairman/CEO. Further plans are to cut the 30 minute commercial to 1-2 minutes for airing on cable TV into millions of US households, getting the most out of the original production costs. About Med Gen Inc. Med Gen Inc., in business since 1996, manufactures and markets specialty products using its proprietary delivery system Spray�s the Way (�STW�). It is best known for producing the world�s first patented liquid spray snoring relief formula, Snorenz�. Since its existence, Med Gen has continued to develop its STW technology, introducing Good Nights Sleep�, the UnDiet� system and GOOD NIGHTS SLEEP� Sleep Strips into its family of brands. FabULust�, the company�s newest product, a female sexual stimulant, has been launched in test markets throughout the country. While STW technology is mainly used, the company also produces other products that deal with common health issues using other delivery systems. The company markets its products to distributors, direct sales via the company web site and direct to consumer television, radio and print advertising. The company also distributes its brands internationally under various private labels or existing names. The Company also offers specialty financial and investment services through its Financial Services division, to small emerging public companies. Med Gen Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol �MDIN�. For information contact Investor Relations 561-750-1100 or www.medgen.com This Press Release contains or incorporates by reference forward looking statements including certain information with respect to plans and strategies of Med Gen Inc. For this purpose, any statements contained herein or incorporated herein by references that are not statements of historical fact may be deemed forward looking statements. Without limiting the foregoing, the words �believes�, �suggests�, �anticipates�, �plans�, �expects�, and similar expressions are intended to identify forward looking statements. There are a number of events or actual results of Med Gen operations that could differ materially from those indicated by such forward looking statements.